Accuracy of 18F‐FDG‐PET/CT for staging of oral squamous cell carcinoma

This study prospectively assessed 2‐[F18]‐fluoro‐2‐deoxy‐D‐glucose–positron emission tomography (18F‐FDG‐PET)/CT (PET/CT) in oral squamous cell carcinoma.

[1]  G. Cook,et al.  Pitfalls in PET/CT interpretation. , 2007, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[2]  V. Treyer,et al.  Objective and subjective comparison of standard 2-D and fully 3-D reconstructed data on a PET/CT system , 2007, Nuclear medicine communications.

[3]  S. Heiba,et al.  Impact of PET/CT in Comparison With Same Day Contrast Enhanced CT in Breast Cancer Management , 2007, Clinical nuclear medicine.

[4]  Heinrich R Schelbert,et al.  Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  J. Shah,et al.  Neck dissection: then and now. , 2006, Auris, nasus, larynx.

[6]  B. Sanghera,et al.  Clinical Study of 2D and 3D Scan Time Reduction in Head / Neck Cancer with BGO Based PET / CT using Statistical Image Analysis , 2006, 2006 IEEE Nuclear Science Symposium Conference Record.

[7]  T. Yen,et al.  Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  M. Thakur,et al.  99mTc-Fanolesomab: affinity, pharmacokinetics and preliminary evaluation. , 2006, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[9]  Y. Erdi,et al.  18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  Marc Kachelriess,et al.  Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  J. Shah,et al.  Second primary malignancy of the aerodigestive tract in patients treated for cancer of the oral cavity and larynx , 2005, Head & neck.

[12]  Abass Alavi,et al.  Potential of dual-time-point imaging to improve breast cancer diagnosis with (18)F-FDG PET. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  G. Goerres,et al.  Bone invasion in patients with oral cavity cancer: comparison of conventional CT with PET/CT and SPECT/CT. , 2005, Radiology.

[14]  C. Snyderman,et al.  Head and neck malignancy: is PET/CT more accurate than PET or CT alone? , 2005, Radiology.

[15]  M. Fukui,et al.  Role of 18FFDG PET/CT in the treatment of head and neck cancers: principles, technique, normal distribution, and initial staging. , 2005, AJR. American journal of roentgenology.

[16]  A. Alavi,et al.  Investigation of thyroid, head, and neck cancers with PET. , 2004, Radiologic clinics of North America.

[17]  Jean-François Daisne,et al.  Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. , 2004, Radiology.

[18]  H. Schöder,et al.  Positron emission imaging of head and neck cancer, including thyroid carcinoma. , 2004, Seminars in nuclear medicine.

[19]  Mithat Gonen,et al.  Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. , 2004, Radiology.

[20]  R. Nicoletti,et al.  Preoperative Image Fusion of Fluoro-2-Deoxy-d-Glucose–Positron Emission Tomography and Computed Tomography Data Sets in Oral Maxillofacial Carcinoma: Potential Clinical Value , 2003, Journal of computer assisted tomography.

[21]  L. Mortelmans,et al.  FDG-PET: procedure guidelines for tumour imaging , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[22]  G. V. von Schulthess,et al.  Impact of whole body positron emission tomography on initial staging and therapy in patients with squamous cell carcinoma of the oral cavity. , 2003, Oral oncology.

[23]  H. Kundel,et al.  Measurement of observer agreement. , 2003, Radiology.

[24]  W. Waddington,et al.  A new approach to pre-treatment assessment of the N0 neck in oral squamous cell carcinoma: the role of sentinel node biopsy and positron emission tomography. , 2003, Oral oncology.

[25]  S. Stoeckli,et al.  Is there a role for positron emission tomography with 18F‐fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma , 2002, Head & neck.

[26]  Tomio Inoue,et al.  The role of whole-body FDG-PET in preoperative assessment of tumor staging in oral cancers , 2001, Annals of nuclear medicine.

[27]  R. Baum,et al.  Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI. , 2000, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[28]  H. Curtin,et al.  Lymph node pathology. Benign proliferative, lymphoma, and metastatic disease. , 2000, Radiologic clinics of North America.

[29]  F. Cianfriglia,et al.  Multiple primary tumours in patients with oral squamous cell carcinoma. , 1999, Oral oncology.

[30]  Richard A. Szucs,et al.  TNM Classification of Malignant Tumors. 5th ed , 1998 .

[31]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.

[32]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.